Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in...

ha aggiunto una foto Health

2026-03-13 09:25:33 - Translate -

Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma Therapies

According to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...

0 Commenti 0 condivisioni 394 Views 0 Anteprima